Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
Children's Hospital of Philadelphia · Penn Presbyterian Medical Center · +11 more institutions
Abstract
Leber's congenital amaurosis (LCA) is a group of inherited blinding diseases with onset during childhood. One form of the disease, LCA2, is caused by mutations in the retinal pigment epithelium-specific 65-kDa protein gene (RPE65). We investigated the safety of subretinal delivery of a recombinant adeno-associated virus (AAV) carrying RPE65 complementary DNA (cDNA) (ClinicalTrials.gov number, NCT00516477 [ClinicalTrials.gov]). Three patients with LCA2 had an acceptable local and systemic adverse-event profile after delivery of AAV2.hRPE65v2. Each patient had a modest improvement in measures of retinal function on subjective tests of visual acuity. In one patient, an asymptomatic macular hole developed, and…
Citation impact
- FWCI
- 71.73
- Percentile
- 100%
- References
- 27
Authors
32- AMAlbert M. MaguireCorresponding
Children's Hospital of Philadelphia, Penn Presbyterian Medical Center, University of Pennsylvania
- FSFrancesca Simonelli
University of Naples Federico II
- EAEric A. Pierce
Penn Presbyterian Medical Center, University of Pennsylvania
- ENEdward N. Pugh
- FMFederico Mingozzi
Children's Hospital of Philadelphia
Topics & keywords
- Medicine
- RPE65
- Cis-trans-Isomerases
- Retinal pigment epithelium
- Visual acuity
- Blinding
- Adverse effect
- Genetic enhancement
- Good health and well-being